Sitting Down With… Mike Barnes, Chief Medical Officer, Lyphe Group Chairman, Maple Tree Consultancy.
Ill-considered regulations have resulted in an analytical race to the bottom.
The need for open and ongoing discussion between scientists, clinicians, regulators, and patients has never been clearer.
Heavy metal contaminants pose a risk to health – the cannabis industry must react accordingly.
Restrictive legislation won’t prevent efforts to progress cannabis research
Regulating cannabis vape flavors may have negative consequences for wider cannabis research… Unless industry acts quickly.
Celebrating the pioneers at the forefront of cannabis science.
Sitting Down With… John Abrams, The Clinical Endocannabinoid System Consortium (CESC) and Abrams BioConsulting, San Diego, California, USA.
Scientists must come together to share experiences, accumulate evidence, and bring about change in cannabis policy.
Get up to speed on some of the latest cannabis content hitting headlines.
The cannabis universe is evolving rapidly, but how will newcomers shape the field?
Cannabis testing: regulation, evolution and the need for nuanced debate.
Two experts explore the impact that legalization will have on science, business and human health.
Send me the latest from The Cannabis Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.